TSLP: contrasting roles in cancer

Thymic stromal lymphopoietin (TSLP) is an alarmin cytokine possessing a plethora of pleiotropic properties. Human and mouse TSLP exerts their activity via a heterodimeric complex composed of TSLP receptor (TSLPR) chain and IL-7Rα. TSLP is predominantly expressed by epithelial cells and keratinocytes...

Full description

Saved in:
Bibliographic Details
Main Authors: Remo Poto, Gianni Marone, Steven F. Ziegler, Gilda Varricchi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1627235/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849407363109355520
author Remo Poto
Remo Poto
Remo Poto
Gianni Marone
Gianni Marone
Gianni Marone
Steven F. Ziegler
Steven F. Ziegler
Steven F. Ziegler
Gilda Varricchi
Gilda Varricchi
Gilda Varricchi
author_facet Remo Poto
Remo Poto
Remo Poto
Gianni Marone
Gianni Marone
Gianni Marone
Steven F. Ziegler
Steven F. Ziegler
Steven F. Ziegler
Gilda Varricchi
Gilda Varricchi
Gilda Varricchi
author_sort Remo Poto
collection DOAJ
description Thymic stromal lymphopoietin (TSLP) is an alarmin cytokine possessing a plethora of pleiotropic properties. Human and mouse TSLP exerts their activity via a heterodimeric complex composed of TSLP receptor (TSLPR) chain and IL-7Rα. TSLP is predominantly expressed by epithelial cells and keratinocytes but can also be produced by several immune cells and some cancers. TSLP activates a plethora of immune cells implicated in inflammation, angiogenesis and tumorigenesis. In addition to its role in barrier immunity, recent studies have a role for TSLP in cancer development. This includes both human hematologic cancers and several solid tumors (largely carcinomas). The role of TSLP in human and experimental cancers has been the focus of several studies, with somewhat contradictory findings. In this Review, we will highlight recent advances in TSLP immunobiology in the context of human and experimental cancers. We will also discuss recent findings demonstrating that an anti-TSLP monoclonal antibody (mAb) can exert a protective effect in a mouse model of colorectal cancer. The recent approval of an anti-TSLP mAb for asthma treatment also emphasizes the urgent need for additional research on the role of TSLP, a Janus cytokine, in tumorigenesis.
format Article
id doaj-art-4a17bad29c874322aaf5192811790301
institution Kabale University
issn 1664-3224
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-4a17bad29c874322aaf51928117903012025-08-20T03:36:06ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-08-011610.3389/fimmu.2025.16272351627235TSLP: contrasting roles in cancerRemo Poto0Remo Poto1Remo Poto2Gianni Marone3Gianni Marone4Gianni Marone5Steven F. Ziegler6Steven F. Ziegler7Steven F. Ziegler8Gilda Varricchi9Gilda Varricchi10Gilda Varricchi11Department of Translational Medical Sciences, University of Naples Federico II, Naples, ItalyIstituti Clinici Scientifici Maugeri-Scientific Institute for Research Hospitalization and Healthcare (IRCCS) Scientific Institute of Telese Terme, Benevento, ItalyWorld Allergy Organization (WAO), Center of Excellence (CoE), Naples, ItalyDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, ItalyWorld Allergy Organization (WAO), Center of Excellence (CoE), Naples, ItalyCenter for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, ItalyBenaroya Research Institute, Seattle, WA, United StatesDivision of Allergy and Infectious Diseases, University of Washington, Seattle, WA, United StatesDepartment of Immunology, University of Washington, Seattle, WA, United StatesDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, ItalyWorld Allergy Organization (WAO), Center of Excellence (CoE), Naples, ItalyCenter for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, ItalyThymic stromal lymphopoietin (TSLP) is an alarmin cytokine possessing a plethora of pleiotropic properties. Human and mouse TSLP exerts their activity via a heterodimeric complex composed of TSLP receptor (TSLPR) chain and IL-7Rα. TSLP is predominantly expressed by epithelial cells and keratinocytes but can also be produced by several immune cells and some cancers. TSLP activates a plethora of immune cells implicated in inflammation, angiogenesis and tumorigenesis. In addition to its role in barrier immunity, recent studies have a role for TSLP in cancer development. This includes both human hematologic cancers and several solid tumors (largely carcinomas). The role of TSLP in human and experimental cancers has been the focus of several studies, with somewhat contradictory findings. In this Review, we will highlight recent advances in TSLP immunobiology in the context of human and experimental cancers. We will also discuss recent findings demonstrating that an anti-TSLP monoclonal antibody (mAb) can exert a protective effect in a mouse model of colorectal cancer. The recent approval of an anti-TSLP mAb for asthma treatment also emphasizes the urgent need for additional research on the role of TSLP, a Janus cytokine, in tumorigenesis.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1627235/fullalarmincancer immunitycytokineTSLPTSLP isoformstumor microenvironment
spellingShingle Remo Poto
Remo Poto
Remo Poto
Gianni Marone
Gianni Marone
Gianni Marone
Steven F. Ziegler
Steven F. Ziegler
Steven F. Ziegler
Gilda Varricchi
Gilda Varricchi
Gilda Varricchi
TSLP: contrasting roles in cancer
Frontiers in Immunology
alarmin
cancer immunity
cytokine
TSLP
TSLP isoforms
tumor microenvironment
title TSLP: contrasting roles in cancer
title_full TSLP: contrasting roles in cancer
title_fullStr TSLP: contrasting roles in cancer
title_full_unstemmed TSLP: contrasting roles in cancer
title_short TSLP: contrasting roles in cancer
title_sort tslp contrasting roles in cancer
topic alarmin
cancer immunity
cytokine
TSLP
TSLP isoforms
tumor microenvironment
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1627235/full
work_keys_str_mv AT remopoto tslpcontrastingrolesincancer
AT remopoto tslpcontrastingrolesincancer
AT remopoto tslpcontrastingrolesincancer
AT giannimarone tslpcontrastingrolesincancer
AT giannimarone tslpcontrastingrolesincancer
AT giannimarone tslpcontrastingrolesincancer
AT stevenfziegler tslpcontrastingrolesincancer
AT stevenfziegler tslpcontrastingrolesincancer
AT stevenfziegler tslpcontrastingrolesincancer
AT gildavarricchi tslpcontrastingrolesincancer
AT gildavarricchi tslpcontrastingrolesincancer
AT gildavarricchi tslpcontrastingrolesincancer